Hematopoietic stem cell transplantation for children with high-risk acute lymphoblastic leukemia in first complete remission: a report from the AIEOP registry.
about
Role of Pharmacogenetics in Hematopoietic Stem Cell Transplantation Outcome in ChildrenFavorable outcome in children and adolescents with a high proportion of advanced phase disease using single/multiple autologous or matched/mismatched allogeneic stem cell transplantations.Reduced-toxicity myeloablative conditioning consisting of 8-Gy total body irradiation, cyclophosphamide and fludarabine for pediatric hematological malignancies.Minimal Residual Disease Evaluation in Childhood Acute Lymphoblastic Leukemia: An Economic Analysis.Preventing relapse after haematopoietic stem cell transplantation for acute leukaemia: the role of post-transplantation minimal residual disease (MRD) monitoring and MRD-directed intervention.Comparison of outcomes after umbilical cord blood and unmanipulated haploidentical hematopoietic stem cell transplantation in children with high-risk acute lymphoblastic leukemia.Outcome of children with acute myeloid leukaemia (AML) experiencing primary induction failure in the AIEOP AML 2002/01 clinical trial.Comparison of chemotherapeutic agents as a myeloablative conditioning with total body irradiation for pediatric acute lymphoblastic leukemia: A study from the pediatric ALL working group of the Japan Society for Hematopoietic Cell Transplantation.Risk assessment of relapse by lineage-specific monitoring of chimerism in children undergoing allogeneic stem cell transplantation for acute lymphoblastic leukemiaFollow-up of post-transplant minimal residual disease and chimerism in childhood lymphoblastic leukaemia: 90 d to react.Hematopoietic Stem Cell Transplantation for Childhood Acute Lymphoblastic Leukemia and the Role of MRD: A Single Centre Experience from India.Improved outcome of children transplanted for high-risk leukemia by using a new strategy of cyclosporine-based GVHD prophylaxis.
P2860
Q26798470-E5A238AE-203E-4349-8363-A15E30801077Q30315865-2EFE7442-E0F3-4681-A091-98055BE19640Q34460533-8819973D-49CA-44B9-9961-FE6E5352351DQ36731638-5C78B9DE-6E48-4A68-8D94-8832E4B7017AQ39329093-BF22FD06-1C7D-4BCE-BBCD-3D287A5BCDCBQ40675515-FB353AB7-D154-4FA9-B40F-8B15F1A8E529Q40681571-18541EC7-991D-4FC5-9FF2-C04EDE6E8ACCQ40858788-5482AAC6-FBB5-418A-9EFC-B95FF194A3A5Q41032396-A7A9E8A8-2660-407D-A3C7-1AD2F2B955F8Q47209362-9E7B91F8-2A4F-4C06-89B8-96A6513CD6D0Q48109702-219257E2-4293-42E3-AFCE-8EF03B55E1B5Q50887405-C58F87C2-F81E-42E5-8AF2-F2F08B8DE65C
P2860
Hematopoietic stem cell transplantation for children with high-risk acute lymphoblastic leukemia in first complete remission: a report from the AIEOP registry.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 February 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hematopoietic stem cell transp ...... eport from the AIEOP registry.
@en
Hematopoietic stem cell transp ...... eport from the AIEOP registry.
@nl
type
label
Hematopoietic stem cell transp ...... eport from the AIEOP registry.
@en
Hematopoietic stem cell transp ...... eport from the AIEOP registry.
@nl
prefLabel
Hematopoietic stem cell transp ...... eport from the AIEOP registry.
@en
Hematopoietic stem cell transp ...... eport from the AIEOP registry.
@nl
P2093
P2860
P1433
P1476
Hematopoietic stem cell transp ...... eport from the AIEOP registry.
@en
P2093
Adriana Balduzzi
Arcangelo Prete
Carla Rognoni
Chiara Messina
Claudio Favre
Edoardo Lanino
Franca Fagioli
Giuseppe Basso
Marco Zecca
Mimmo Ripaldi
P2860
P304
P356
10.3324/HAEMATOL.2012.079707
P577
2013-02-26T00:00:00Z